Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of ALKEM LABORATORIES. For more details, see the ALKEM LABORATORIES quarterly results and ALKEM LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 3.1 |
No. of shares | m | 119.57 |
1 Week | % | 4.5 |
1 Month | % | -2.9 |
1 Year | % | 41.6 |
52 week H/L | Rs | 5,519.1/3,211.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ALKEM LABORATORIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,265 | 2,720 | 3,150 | 4,068 | 3,625 | |
Low | Rs | 1,693 | 1,660 | 2,224 | 2,671 | 2,835 | |
Sales per share (Unadj.) | Rs | 615.3 | 697.9 | 741.4 | 889.4 | 970.1 | |
Earnings per share (Unadj.) | Rs | 64.7 | 96.1 | 135.3 | 140.5 | 84.2 | |
Diluted earnings per share | Rs | 64.7 | 96.1 | 135.3 | 140.5 | 84.2 | |
Cash flow per share (Unadj.) | Rs | 80.9 | 117.3 | 158.3 | 166.0 | 110.2 | |
Dividends per share (Unadj.) | Rs | 16.00 | 25.00 | 30.00 | 34.00 | 50.00 | |
Adj. dividends per share | Rs | 16.00 | 25.00 | 30.00 | 34.00 | 50.00 | |
Avg Dividend yield | % | 0.8 | 1.1 | 1.1 | 1.0 | 1.5 | |
Book value per share (Unadj.) | Rs | 454.8 | 515.1 | 616.8 | 722.4 | 756.4 | |
Adj. book value per share | Rs | 454.8 | 515.1 | 616.9 | 722.4 | 756.5 | |
Shares outstanding (eoy) | m | 119.57 | 119.57 | 119.57 | 119.57 | 119.57 | |
Price / Sales ratio | x | 3.2 | 3.1 | 3.6 | 3.8 | 3.3 | |
Avg P/E ratio | x | 30.6 | 22.8 | 19.9 | 24.0 | 38.4 | |
P/CF ratio (eoy) | x | 24.5 | 18.7 | 17.0 | 20.3 | 29.3 | |
Price / Book Value ratio | x | 4.4 | 4.3 | 4.4 | 4.7 | 4.3 | |
Dividend payout | % | 24.7 | 26.0 | 22.2 | 24.2 | 59.4 | |
Avg Mkt Cap | Rs m | 236,619 | 261,868 | 321,244 | 402,868 | 386,207 | |
Total wages/salary | Rs m | 13,625 | 15,055 | 16,210 | 19,627 | 21,314 |
ALKEM LABORATORIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 73,572 | 83,444 | 88,650 | 106,342 | 115,993 | |
Other income | Rs m | 877 | 1,042 | 2,332 | 1,627 | 2,161 | |
Total revenues | Rs m | 74,449 | 84,486 | 90,982 | 107,968 | 118,153 | |
Gross profit | Rs m | 11,148 | 14,734 | 19,424 | 20,380 | 15,065 | |
Depreciation | Rs m | 1,932 | 2,528 | 2,746 | 3,040 | 3,104 | |
Interest | Rs m | 546 | 651 | 589 | 524 | 1,074 | |
Profit before tax | Rs m | 9,547 | 12,598 | 18,421 | 18,443 | 13,048 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,810 | 1,105 | 2,243 | 1,640 | 2,980 | |
Profit after tax | Rs m | 7,736 | 11,493 | 16,178 | 16,803 | 10,068 | |
Gross profit margin | % | 15.2 | 17.7 | 21.9 | 19.2 | 13.0 | |
Effective tax rate | % | 19.0 | 8.8 | 12.2 | 8.9 | 22.8 | |
Net profit margin | % | 10.5 | 13.8 | 18.2 | 15.8 | 8.7 |
ALKEM LABORATORIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 42,044 | 54,876 | 69,233 | 84,337 | 86,064 | |
Current liabilities | Rs m | 22,175 | 32,446 | 36,041 | 48,053 | 37,071 | |
Net working cap to sales | % | 27.0 | 26.9 | 37.4 | 34.1 | 42.2 | |
Current ratio | x | 1.9 | 1.7 | 1.9 | 1.8 | 2.3 | |
Inventory Days | Days | 24 | 18 | 20 | 42 | 33 | |
Debtors Days | Days | 62 | 72 | 66 | 65 | 67 | |
Net fixed assets | Rs m | 32,844 | 35,073 | 34,825 | 43,245 | 37,245 | |
Share capital | Rs m | 239 | 239 | 239 | 239 | 239 | |
"Free" reserves | Rs m | 54,139 | 61,354 | 73,517 | 86,134 | 90,208 | |
Net worth | Rs m | 54,378 | 61,593 | 73,756 | 86,373 | 90,447 | |
Long term debt | Rs m | 2,313 | 739 | 279 | 94 | 0 | |
Total assets | Rs m | 75,006 | 90,130 | 104,114 | 127,599 | 124,541 | |
Interest coverage | x | 18.5 | 20.4 | 32.3 | 36.2 | 13.2 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.0 | 0.9 | 0.9 | 0.8 | 0.9 | |
Return on assets | % | 11.0 | 13.5 | 16.1 | 13.6 | 8.9 | |
Return on equity | % | 14.2 | 18.7 | 21.9 | 19.5 | 11.1 | |
Return on capital | % | 17.8 | 21.3 | 25.7 | 21.9 | 15.6 | |
Exports to sales | % | 16.6 | 19.2 | 22.1 | 18.7 | 14.6 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 12,238 | 16,061 | 19,555 | 19,924 | 16,916 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 12,238 | 16,061 | 19,555 | 19,924 | 16,916 | |
Fx outflow | Rs m | 2,105 | 2,483 | 2,467 | 3,911 | 4,190 | |
Net fx | Rs m | 10,133 | 13,578 | 17,088 | 16,013 | 12,727 |
ALKEM LABORATORIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 7,797 | 5,851 | 12,649 | 11,110 | 16,825 | |
From Investments | Rs m | -3,164 | -7,414 | -9,985 | -14,351 | 1,128 | |
From Financial Activity | Rs m | -3,789 | 792 | -2,718 | 3,796 | -17,608 | |
Net Cashflow | Rs m | 823 | -731 | -17 | 580 | 416 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Basudeo N Singh | COMP SEC: Manish Narang | YEAR OF INC: 1973 | BSE CODE: 539523 | FV (Rs): 2 | DIV YIELD (%): 1.0 |
Read: ALKEM LABORATORIES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ALKEM LABORATORIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.